Rhumbline Advisers Has $175.43 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX

NodeGuardian · 2026-02-20T16:07:37+00:00

Rhumbline Advisers decreased its Vertex Pharmaceuticals stake by 1.4% to 447,928 shares worth $175.43 million. Meanwhile, other investors increased their holdings. Analysts maintain a positive outlook with a "Moderate Buy" rating and a target price of $522.68.

NodeGuardian

2026-02-20 16:07:37

Abstract generation in progress

Rhumbline Advisers reduced its stake in Vertex Pharmaceuticals (NASDAQ:VRTX) by 1.4% in the third quarter, holding 447,928 shares valued at $175.43 million. Other institutional investors also adjusted their positions, with notable increases from Chesapeake Asset Management LLC and Financial Network Wealth Advisors LLC. Analyst ratings for VRTX are largely positive, with an average “Moderate Buy” rating and a price target of $522.68.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.